Prelude Therapeutics PRLD Ratios (2019-2026)

NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Prelude Therapeutics Quarterly Ratios

Periods 27 quarters
Latest Jun 2026

Prelude Therapeutics reported a net margin of -244.06% for the quarter ended Jun 2026. These financial ratios cover 27 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
-1,145.87%-845.78%-314.12%-307.59%-309.54%-270.93%
EBIT Margin
-1,145.87%-845.78%-314.12%-307.59%-309.54%-270.93%
EBITDA Margin
-1,132.37%-833.55%-307.58%-300.18%-301.00%-264.74%
Operating Margin
-1,145.87%-845.78%-314.12%-307.59%-309.54%-270.93%
Net Margin
-1,075.70%-718.28%-303.46%-291.79%-226.75%-244.06%
FCF Margin
-911.97%-519.93%-294.08%409.91%-473.47%-273.04%
Efficiency
Assets AverageAssets Avg.
340.40M318.16M292.88M269.86M250.69M231.41M209.41M239.47M269.56M268.09M262.39M235.70M210.76M186.37M158.39M128.09M104.84M118.03M130.48M154.50M
Equity AverageEquity Avg.
322.80M298.57M273.85M251.33M229.13M206.42M185.37M218.68M250.16M237.67M223.91M196.50M169.35M143.94M117.32M89.51M67.19M63.59M64.41M96.96M
Asset Utilization RatioAsset Util.
0.050.100.100.130.15
Valuation
Price to SalesP/S
8.798.6215.0516.2918.97
Price to BookP/B
4.742.071.261.041.461.481.560.940.710.991.701.581.000.730.570.811.552.664.533.18
Enterprise Value
1,154.61M297.74M58.87M-0.66M88.27M83.62M97.04M-12.39M-65.14M-2.47M153.02M104.77M-0.65M-41.38M-44.61M-15.70M24.90M76.26M127.79M144.72M
Market Capitalization
1,475.48M593.02M329.10M249.69M316.35M289.39M273.34M246.64M169.41M234.51M358.99M288.65M157.02M96.27M58.51M61.56M90.53M182.71M272.39M425.35M
Return Ratios
Return on Sales [ROS]ROS
-1,145.87%-845.78%-1,928.67%-314.12%-307.59%-309.54%-270.93%
Return on Capital Employed [ROCE]ROCE
-31.23%-38.04%-44.09%-48.65%-53.75%-58.91%-64.49%-55.87%-50.77%-53.71%-56.18%-66.99%-75.99%-86.93%-100.99%-125.96%-139.70%-160.77%-94.79%-57.87%
Return on Assets [ROA]ROA
-29.43%-35.75%-41.67%-45.80%-49.13%-53.38%-58.43%-52.33%-47.59%-49.34%-52.41%-60.36%-67.98%-74.97%-88.38%-105.40%-115.46%-88.59%-64.48%-43.62%
Return on Equity [ROE]ROE
-31.03%-38.09%-44.57%-49.18%-53.75%-59.85%-66.01%-57.30%-51.28%-55.65%-61.41%-72.40%-84.59%-97.06%-119.31%-150.83%-180.17%-164.45%-130.63%-69.51%

Prelude Therapeutics Ratios API

Pull Prelude Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PRLD&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY